Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. [electronic resource]
Producer: 20031017Description: 564-70 p. digitalISSN:- 0015-0282
- Adolescent
- Adult
- Contraceptive Agents, Female -- administration & dosage
- Drug Implants
- Endometrium -- metabolism
- Female
- Humans
- Immunohistochemistry -- methods
- Levonorgestrel -- administration & dosage
- Matrix Metalloproteinases -- metabolism
- Matrix Metalloproteinases, Secreted
- Menstrual Cycle -- metabolism
- Prospective Studies
- Reference Values
- Staining and Labeling
- Tissue Inhibitor of Metalloproteinase-3 -- metabolism
- Tissue Inhibitor of Metalloproteinases -- metabolism
- Uterine Hemorrhage -- chemically induced
- Tissue Inhibitor of Metalloproteinase-4
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.